There's a surprisingly simple reason why the US spent $3 billion on drugs that were never used
AstraZeneca to Buy U.S. Cancer Firm for Up to $500M
Why Samsung Electronics Should Say No to Drugs
It's Getting Harder to Come Up With a Successful Drug
The Problem with Fast-Tracking Drug Approvals: Pharmas Fail to Follow Up
Inside Wall Street: Is ImmunoCellular Another Rising Star in Biotech?